|
|
|
Volumn 25, Issue 1 SUPPL. 2, 1998, Pages 2-7
|
|
Ifosfamide and paclitaxel combinations for the treatment of advanced non-small cell lung cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
IFOSFAMIDE;
PACLITAXEL;
PLATINUM DERIVATIVE;
ADVANCED CANCER;
ARTICLE;
BONE MARROW SUPPRESSION;
BRAIN DISEASE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
FEVER;
HEART ARRHYTHMIA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
LUNG TOXICITY;
MAJOR CLINICAL STUDY;
NEPHROTOXICITY;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
THROMBOCYTOPENIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CLINICAL TRIALS;
ETOPOSIDE;
HUMANS;
IFOSFAMIDE;
LUNG NEOPLASMS;
PACLITAXEL;
PLATINUM COMPOUNDS;
|
|
EID: 0031956320
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (27)
|
